Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development, preliminary usability and accuracy testing of the EBMT 'eGVHD App' to support GvHD assessment according to NIH criteria-a proof of concept.
Schoemans H, Goris K, Durm RV, Vanhoof J, Wolff D, Greinix H, Pavletic S, Lee SJ, Maertens J, Geest SD, Dobbels F, Duarte RF. Schoemans H, et al. Among authors: greinix h. Bone Marrow Transplant. 2016 Aug;51(8):1062-5. doi: 10.1038/bmt.2016.26. Epub 2016 Apr 4. Bone Marrow Transplant. 2016. PMID: 27042834
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.
Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P, Bourquelot P, Greinix H, Frickhofen N, Ringdén O, Zander A, Apperley JF, Gorin C, Borkett K, Schwab G, Goebel M, Russell NH, Gratwohl A. Schmitz N, et al. Among authors: greinix h. Bone Marrow Transplant. 1998 May;21(10):995-1003. doi: 10.1038/sj.bmt.1701234. Bone Marrow Transplant. 1998. PMID: 9632272 Clinical Trial.
Criteria for assessing chronic GVHD.
Greinix HT, Volc-Platzer B, Knobler R. Greinix HT, et al. Bone Marrow Transplant. 2000 Mar;25(5):575. doi: 10.1038/sj.bmt.1702183. Bone Marrow Transplant. 2000. PMID: 10713639 No abstract available.
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A, Höcker P, Dieckmann K, Fischer G, Rosenmayr A, Linkesch W, Hinterberger W, Lechner K, Greinix HT. Worel N, et al. Among authors: greinix ht. Bone Marrow Transplant. 2002 Nov;30(9):619-26. doi: 10.1038/sj.bmt.1703677. Bone Marrow Transplant. 2002. PMID: 12407437
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT); European Group for Blood and Marrow Transplantation EBMT (JACIE). Gratwohl A, et al. Bone Marrow Transplant. 2008 Apr;41(8):687-705. doi: 10.1038/sj.bmt.1705956. Epub 2007 Dec 17. Bone Marrow Transplant. 2008. PMID: 18084334
Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
Hildebrandt GC, Granell M, Urbano-Ispizua A, Wolff D, Hertenstein B, Greinix HT, Brenmoehl J, Schulz C, Dickinson AM, Hahn J, Rogler G, Andreesen R, Holler E. Hildebrandt GC, et al. Biol Blood Marrow Transplant. 2008 Jan;14(1):67-74. doi: 10.1016/j.bbmt.2007.09.009. Biol Blood Marrow Transplant. 2008. PMID: 18158963 Free article.
384 results